share_log

D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target

Benzinga ·  07:02  · Ratings

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment